Dr. Bezabeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
110 Irving St NW
Washington, DC 20010Phone+1 202-877-9696Fax+1 202-877-9263
Summary
- Dr. Shewit Bezabeh is an internist in Washington, DC and is affiliated with MedStar Washington Hospital Center. He received his medical degree from University of California Irvine School of Medicine and has been in practice 29 years. He specializes in hospital medicine/hospitalist and preventive medicine and is experienced in diabetes mellitus, hospitalist medicine, emergency medicine, epidemiology, and health technology/informatics.
Education & Training
- Johns Hopkins Bloomberg School of Public HealthResidency, Public Health and General Preventive Medicine, 1994 - 1996
- Johns Hopkins Bloomberg School of Public HealthFellowship, Public Health and General Preventive Medicine, 1994 - 1996
- University of California (Irvine)Residency, Internal Medicine, 1987 - 1990
- University of California, Irvine, School of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1988 - Present
- DC State Medical License 1997 - 2026
- MD State Medical License 1994 - 2026
- VA State Medical License 1999 - 2002
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 58 citationsAccumulating Evidence for a Drug–Drug Interaction Between Methotrexate and Proton Pump InhibitorsShewit Bezabeh, Ann Corken Mackey, Paul G. Kluetz, Dilara Jappar, Joyce Korvick
The Oncologist. 2012-04-01 - 95 citationsProgressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients.Namita Kothary, Ida Lina Diak, Allen Brinker, Shewit Bezabeh, Mark I. Avigan
Journal of the American Academy of Dermatology. 2011-09-01 - 56 citationsClinically significant liver injury in patients treated with natalizumab.S. Bezabeh, Charlene M. Flowers, Cindy Kortepeter, Mark I. Avigan
Alimentary Pharmacology & Therapeutics. 2010-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: